Want to join the conversation?
Adhesives and sealants manufacturer $FUL reported 1Q16 net income of $18.9MM or $0.37 per diluted share versus net income of $9.7MM or $0.19 per diluted share in 1Q15. Net revenue grew 0.8% from last year to $474.3MM. Adjusted diluted EPS was $0.431, up 43% versus 1Q15 adjusted result of $0.301.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?